Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new revision: v3.3.2, and the previous revision v3.3.1 is removed; no study details appear to be modified.SummaryDifference0.0%

- Check21 days agoChange DetectedUpdated the Publications section description to indicate that publications are automatically filled from PubMed, a public database, and may not be about the study. Revision label updated from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoved the site-wide government funding lapse notice from the study page.SummaryDifference0.2%

- Check43 days agoChange Detected- No significant changes detected in the study details between the two screenshots. The core content, including study title, objectives, eligibility criteria, interventions, and outcomes, appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check72 days agoChange Detected- Add: government funding notice, new topic on diffuse large B-cell lymphoma, and version bump to v3.2.0; - Remove: old version tag v3.1.0.SummaryDifference2%

- Check79 days agoChange DetectedUpgraded to v3.1.0 by removing the topic 'Diffuse large B-cell lymphoma' from resources and keeping the version label as the primary change.SummaryDifference0.2%

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.